Clinical trial Recruiting at 1 site Observational Ages 16 and up

Tracking iron rims around MS lesions over time

Official title: Longitudinal Assessment of Iron Rims in White Matter MS Lesions as a Marker of Disability

Run by Nottingham University Hospitals NHS Trust · NCT05123443 · Data updated 2026-11-12

This project will test whether genetic differences predict which people with MS develop iron rims around white matter lesions.

Quick facts

Study typeObservational
Ages16 Years and up
SexAll
Enrollment100 (estimated)
SponsorNottingham University Hospitals NHS Trust
Academic / other
Locations1 site (Nottingham)
StatusRecruiting
StartedSeptember 3, 2022
Main results expectedJuly 31, 2026
Study endsJuly 31, 2027
Registry record updatedMarch 12, 2026
Trial IDNCT05123443 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults (≥16) with a confirmed MS diagnosis who have an existing susceptibility-weighted brain MRI from 2008–2012 and are willing to provide a blood sample and attend a 7T MRI visit.

Probably not a fit

Patients without prior susceptibility-weighted MRI scans, those unable to undergo 7T MRI, or those unwilling or unable to consent are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows a cohort of MS patients who had susceptibility-weighted brain MRI scans between 2008 and 2012 and combines those historic images with new ultra-high-field (7T) and 3T MRI to track iron rim lesions over time. Participants provide blood samples for genotyping to look for genetic variants that might influence the formation or persistence of iron rim lesions. The team will correlate lesion evolution with clinical disability and disease progression measures to see whether iron rims predict a more severe course. Johns Hopkins collaborators and Nottingham University Hospitals will use standardized imaging reads and longitudinal clinical data to analyze lesion dynamics and genetic associations.

Why it matters

Potential benefit: If successful, this work could help identify patients at higher risk of disease progression earlier, enabling more personalized monitoring and treatment decisions.

How similar studies have gone: Previous cross-sectional studies have linked iron rim lesions to progressive MS, but large longitudinal cohorts and genetic linkage studies are limited, making this approach partly supported but still novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women aged above 16 years
* Clinical diagnosis of MS as per revised McDonald Criteria 2017
* Existing susceptibility-weighted brain MRI scan
* Able to provide blood samples

Exclusion Criteria:

* Unwilling or unable to comply with the requirements of this protocol including the presence of any condition (physical, mental or social) that, in the opinion of the PI, is likely to affect the participants ability to comply with the study protocol.
* Unable to provide informed consent.

Where it's running

  • Nottingham University NHS Trust
    Nottingham, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.